Preprint Hypothesis Version 1 Preserved in Portico This version is not peer-reviewed

On the Consequences of Cell Fusion in COVID-19 Patients

Version 1 : Received: 2 June 2021 / Approved: 4 June 2021 / Online: 4 June 2021 (08:21:00 CEST)
Version 2 : Received: 7 September 2021 / Approved: 9 September 2021 / Online: 9 September 2021 (10:54:14 CEST)

A peer-reviewed article of this Preprint also exists.

Journal reference: Oncotarget 2021
DOI: 10.18632/oncotarget.28088

Abstract

This commentary proposes how the coronavirus SARS- CoV-2 can contribute to clinical manifestations of COVID-19 by producing syncytia.

Keywords

cell fusion; syncytia; hybrids; viruses; coronaviruses; SARS-CoV-2; COVID-19; blood coagulation cascade; thrombosis; cancer

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.